Skip to content

Mindful yoga intervention as add-on to treatment as usual for young women with major depressive disorder: Results from a randomized controlled trial.

Nina K. Vollbehr, H J Rogier Hoenders, Agna A. Bartels‐Velthuis, Maaike H. Nauta, Stynke Castelein, Maya J. Schroevers, A Dennis Stant, Casper J Albers, Peter J. de Jong, Brian D. Ostafin

Journal of Consulting and Clinical Psychology December 2022 DOI: 10.1037/ccp0000777 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 171
Population Young women aged 18-34 years with major depressive disorder
Interventions Mindful yoga intervention (MYI) treatment as usual (TAU)
Duration 9-week intervention; assessments at baseline, postintervention, 6- and 12-month follow-up
Measures clinician-rated and self-reported symptoms of depression, diagnostic interview for MDD, quality of life, rumination, self-criticism, self-compassion, intolerance of uncertainty, perceived body awareness, dispositional mindfulness, attentional bias (AB), depression-related self-associations
Topics Depression
Key findings Adding a 9-week mindful yoga intervention to treatment as usual did not lead to greater reduction of depression symptoms, lower rate of MDD diagnosis, or increased quality of life at post-intervention or 6- and 12-month follow-up. No indirect effects were found through the potential mediators, with the exception of self-compassion.

Abstract

To examine the added value of a 9-week mindful yoga intervention (MYI) as add-on to treatment as usual (TAU) in reducing depression for young women (18-34 years) with major depressive disorder (MDD). Randomized controlled trial (RCT; n = 171) comparing TAU + MYI with TAU-only. Assessments were at baseline, postintervention, and at 6- and 12-month follow-up. Primary outcome measures were clinician-rated and self-reported symptoms of depression, together with a diagnostic interview to establish MDD diagnosis that was restricted to the baseline and 12-month follow-up assessments. Quality of life in various domains was assessed as secondary outcome measure. As potential mediators for treatment efficacy, we included self-report measures of rumination, self-criticism, self-compassion, intolerance of uncertainty, perceived body awareness and dispositional mindfulness, together with behavioral measures of attentional bias (AB) and depression-related self-associations. Adding MYI to TAU did not lead to greater reduction of depression symptoms, lower rate of MDD diagnosis or increase in quality of life in various domains of functioning at post and follow-up assessments. There were no indirect effects through any of the potential mediators, with the exception of self-compassion. Adding MYI to TAU appeared not more efficacious than TAU-only in reducing depression symptoms in young women. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 6

and 1 more in the library

Cites 19

and 14 more in the library

Explore topics